Posts

Panag Pharma Announces Health Canada License for a Topical Cold-Sore Formulation NPN 80084806

Panag Pharma announces Health Canada approval for a topical Cold-Sore Formulation, a new generation topical formulation with a dual mechanism of action that improves healing rates and reduces symptoms.